Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
Open Access
- 1 December 2003
- journal article
- Published by Elsevier BV in The Lancet
- Vol. 362 (9400), 1953-1958
- https://doi.org/10.1016/s0140-6736(03)15012-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key EventThe Journal of Infectious Diseases, 2003
- Inhibition of Factor VIIa/Tissue Factor with Nematode Anticoagulant Protein c2 From Unique Mechanism to a Promising New Clinical AnticoagulantTrends in Cardiovascular Medicine, 2002
- Evaluation in Nonhuman Primates of Vaccines against Ebola VirusEmerging Infectious Diseases, 2002
- Dose-Response Study of Recombinant Factor VIIa/Tissue Factor Inhibitor Recombinant Nematode Anticoagulant Protein c2 in Prevention of Postoperative Venous Thromboembolism in Patients Undergoing Total Knee ReplacementCirculation, 2001
- Tissue Factor pathwayBest Practice & Research Clinical Haematology, 1999
- Antiviral Drug Therapy of Filovirus Infections: S‐Adenosylhomocysteine Hydrolase Inhibitors Inhibit Ebola Virus In Vitro and in a Lethal Mouse ModelThe Journal of Infectious Diseases, 1999
- Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus InfectionsThe Journal of Infectious Diseases, 1999
- Disseminated Intravascular Coagulation: Pathophysiological Mechanisms and ManifestationsSeminars in Thrombosis and Hemostasis, 1998
- Inhibition of Ebola virus by S-adenosylhomocysteine hydrolase inhibitorsAntiviral Research, 1995
- Fibrin degradation product D‐dimer induces the synthesis and release of biologically active IL‐1β, IL‐6 and plasminogen activator inhibitors from monocytes in vitroBritish Journal of Haematology, 1994